← All compounds

KLOW80

BPC-157 10mg · GHK-Cu 50mg · TB-500 10mg · KPV 10mg · single blend vial
A$ 400Rp 4.500.000
Bulk buy pricing
3–5 vials
A$ 365
Save ~9%
6–9 vials
A$ 347
Save ~13%
10+ vials
A$ 311
Save ~22%

A single-vial combination of four recovery and repair compounds. BPC-157 for connective tissue and gut repair. GHK-Cu for skin regeneration and collagen. TB-500 for broad tissue healing and cellular migration. KPV for anti-inflammatory support. Each compound amplifies the action of the others.

Compound overview

What it is

KLOW80 combines four complementary mechanisms in a single vial. BPC-157 promotes angiogenesis and connective tissue repair. GHK-Cu activates copper-dependent enzymes involved in collagen synthesis, skin remodelling, and antioxidant defence. TB-500 drives systemic cellular migration to injury sites via actin upregulation. KPV suppresses inflammatory cytokine production via NF-κB inhibition. Together they address healing at the structural, cellular, and inflammatory levels simultaneously.

A comprehensive healing response across skin, connective tissue, gut, and systemic inflammation. Tissue repair accelerates. Skin tone, firmness, and wound healing improve. Inflammatory signals that inhibit healing are dampened. Recovery from physical stress, injury, or chronic inflammation proceeds across multiple fronts from a single reconstitution.

Studied outcomes
  • Each component has independent evidence base — see individual product pages for citations
  • BPC-157: tendon, gut, and angiogenesis
  • GHK-Cu: collagen synthesis, skin regeneration, wound healing
  • TB-500: systemic cellular migration and tissue repair
  • KPV: NF-κB-mediated anti-inflammatory action
Suitability

Who it's for

  • Clients who want a complete recovery cycle without four separate reconstitutions
  • Post-injury or post-surgical recovery — comprehensive multi-pathway support
  • Skin, gut, and systemic inflammation together
  • Complex recovery presentations requiring multiple peptide mechanisms
Who should avoid it
  • Active malignancy — angiogenic components (BPC-157, TB-500, GHK-Cu) are contraindicated
  • Pregnancy
  • Copper sensitivity — GHK-Cu contains copper ions
  • Those needing individuated dose control across each component
Dosing guidance

Protocol guidance

Dose
As per combined component protocols — discuss with your practitioner
Frequency
Typically 3–5 × per week depending on goals
Cycle length
6–12 weeks
Route
Subcutaneous injection
Timing
No strict timing; morning or split AM/PM works
Safety

Contraindications & cautions

  • Contains copper (GHK-Cu) — confirm no copper sensitivity or Wilson disease
  • Angiogenic components require caution in cancer history
  • Dose management is less granular than individual vials — factor this in for sensitive clients
Stacking

Pairs well with

GH secretagogues amplify the anabolic and recovery environment KLOW80 creates

Adds immune regulation on top of the anti-inflammatory and repair profile

Evidence base

Research

See individual compound research — BPC-157, GHK-Cu, TB-500, KPV pages ↗

Not medical advice. Not a substitute for medical care. Consult your licensed practitioner before beginning any protocol. Peptides are sold for research purposes only and are suitable for adults aged 18 years and over.